HALEU is the binding constraint on the entire advanced-reactor buildout and the West is structurally short of it, so Centrus Energy and ASP Isotopes are two ways to own that chokepoint. Centrus is the only US enricher that has actually delivered first-of-a-kind HALEU, over 920 kg under its DOE contract, now extended through 2026 with options for eight more years, and it is profitable at about a $3 billion market cap. ASP Isotopes is the laser-enrichment challenger scaling behind it. x.com 

ASP Isotopes is a speculative but loaded play on silicon-28, huge helium reserves, specialized isotopes for next-generation chipmaking and medical isotopes. Its daily chart shows a Wolfe Wave pointing to about $10.50 next week as a good first step. x.com 

ASP Isotopes is an asymmetric bet on HALEU, the enriched uranium fuel advanced reactors need and the West mostly buys from Russia. Its aerodynamic and laser enrichment processes aim for lower cost and faster builds than centrifuges, and TerraPower signed a 10-year deal for up to 150 tons from 2028. The platform also targets Silicon-28, medical isotopes and lithium. Q1 revenue rose 345% to $4.18M, with $290M of cash and investments; HALEU is a Q4 2026 binary, and Centrus is the safer pick. x.com  … Show more

Oklo's Aurora reactor could turn AI's power bottleneck into a repeatable commercial business if Aurora-INL starts on schedule and later units become cheaper to build. Groves reached first criticality, but its isotope reactor does not prove Aurora's economics. Fuel supply, capital needs and dilution remain major hurdles; a tenfold gain would require a large operating fleet and billions in sustainable revenue and cash flow. x.com 

Nuclear power is the long-term answer to AI's energy needs, best owned in tiers by risk. Constellation, with 20-year Microsoft and Google contracts, and BWX Technologies, a 2.6 book-to-bill reactor servicer, offer steady 15-30% a year. Cameco, Centrus, Oklo and X-Energy target 2-5x; Oklo and X-Energy are pre-revenue bets on 14GW and 5GW pipelines. Uranium Energy, US uranium independence, ASP Isotopes, HALEU enrichment for SMRs, and Ur-Energy, pure uranium leverage, are 10x-or-zero bets. x.com 

Now is the time to buy big into nuclear stocks, since AI cannot survive long-term without nuclear power and small modular reactors. Bank of America now calls SMRs the most consequential energy technologies of the next 25 years. The 100x-potential picks are NuScale, Oklo, ASP Isotopes, X-Energy, Nano Nuclear, Lightbridge and Centrus, with Constellation Energy, Cameco and BWX Technologies as honorable mentions and nuclear and uranium ETFs as broader options. x.com 

The suppliers beneath the big nuclear deals going to Constellation Energy and Vistra get paid while the utilities get the headlines. GE Vernova supplies nuclear equipment, turbines and grid gear; Cameco uranium, fuel and Westinghouse technology; Centrus US enrichment and HALEU for the coming SMR boom; BWX Technologies nuclear components and reactor manufacturing. Oklo is an SMR developer and future fuel customer, while Fluor and Quanta Services add construction and power-infrastructure exposure. … Show more

Centrus Energy controls the real chokepoint in the nuclear trade, HALEU fuel, which next-generation reactors need and almost no one produces domestically. Its new $900 million fixed-price Department of Energy contract, up to $1.07B with options, to expand domestic HALEU production matters more than uranium spot prices. Per @EmmanuelInvest, Centrus plans to move its HALEU cascade to commercial operation, targeting 12 metric tons a year, supporting a $2.4B LEU backlog. x.com 

Oklo is turning its advanced nuclear reactor plans into execution. Its Groves isotope facility in Texas reached criticality on August 5, which Oklo calls the fastest greenfield-to-criticality run for a privately funded reactor in history. Meta signed an agreement letting it prepay for power from a planned 1.2GW Oklo campus in Ohio, the first Aurora powerhouse at Idaho National Laboratory is targeted for 2028, and Oklo holds $3.0B of cash and securities. x.com 

Centrus Energy benefits from nuclear's role as the only carbon-free baseload source that can meet AI's power needs, as the only US-owned company licensed to enrich uranium at commercial scale. It raised 2026 revenue guidance to $450-500 million, holds a $3.9 billion backlog through 2040, and won a $900 million DOE task order for commercial-scale HALEU, the fuel next-generation reactors need but almost no one can make. Its Oak Ridge expansion is advancing with $560 million committed. x.com